
Nearly one of every 20 people who had COVID still haven't recovered completely from their initial infection six to 18 months later, a new study shows, while another 42% say they have only recovered partially from their bout with the...
Read More ›THURSDAY, Oct. 13, 2022 (HealthDay News) -- Over time, men and women under chronic stress face a significantly higher risk that they will die as a result of cancer, a new study warns. The finding comes from an analysis of more than three decades...
Read More ›People with attention-deficit/hyperactivity disorder (ADHD) or narcolepsy may rely on the drug Adderall, but it is in short supply, the U.S. Food and Drug Administration announced Wednesday. The Adderall and Adderall IR shortage is due to...
Read More ›On an August morning, Nicole Tetreault, her husband, Brian, and their 2-year-old daughter, Ella, had eaten breakfast and taken a walk. Nicole hadn't been feeling well since Friday. She'd had a headache and was nauseous. But on Sunday she was...
Read More ›An experimental gene therapy offers hope for rapid improvement in the night vision of adults who have a congenital form of childhood-onset blindness, researchers report. In this ongoing clinical trial at the Scheie Eye Institute in the Perelman...
Read More ›The COVID-19 antiviral Paxlovid has been a game-changer in the global pandemic, shielding high-risk patients from the coronavirus’ most devastating effects. But Paxlovid can itself pose a risk for people taking widely prescribed heart...
Read More ›